ID

22010

Beschrijving

Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00316199

Link

https://clinicaltrials.gov/show/NCT00316199

Trefwoorden

Versies (1)
  1. 14-05-17 14-05-17 -
Geüploaded op

14 mei 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Metastatic Breast Cancer NCT00316199

Engels

Eligibility Metastatic Breast Cancer NCT00316199

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
Beschrijving

breast cancer, gender, chinese origin

Datatype

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0152035
unresectable, locally recurrent breast cancer or stage iv disease.
Beschrijving

breast cancer stage, unresectable, locally recurrent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0027646
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C2986682
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
Beschrijving

response evaluation criteria in solid tumors

Datatype

boolean

Alias
UMLS CUI [1]
C1709926
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
Beschrijving

ecog

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
Beschrijving

anthracycline-base chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0282564
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
Beschrijving

breast cancer, unresectable, locally advanced, metastatic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1519810
UMLS CUI [1,4]
C0677984
UMLS CUI [1,5]
C0027627
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
Beschrijving

concurrent tumor therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0920425
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
Beschrijving

brain metastasis, second primary malignancy

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0751623
active infection or other serious condition.
Beschrijving

infection, comorbidities

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009488
pregnant or breastfeeding.
Beschrijving

pregnancy, breast feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Terug naar het begin van de pagina

Similar models

Eligibility Metastatic Breast Cancer NCT00316199

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
breast cancer, gender, chinese origin
Item
female patients of chinese origin with histologically or cytologically proven diagnosis of breast cancer.
boolean
C0678222 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0152035 (UMLS CUI [3])
breast cancer stage, unresectable, locally recurrent
Item
unresectable, locally recurrent breast cancer or stage iv disease.
boolean
C0678222 (UMLS CUI [1,1])
C0027646 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C2986682 (UMLS CUI [1,4])
response evaluation criteria in solid tumors
Item
have at least one measurable lesion as defined by response evaluation criteria in solid tumors (recist) criteria.
boolean
C1709926 (UMLS CUI [1])
ecog
Item
performance status of 0 or 1 on the eastern cooperative oncology group (ecog) scale
boolean
C1520224 (UMLS CUI [1])
anthracycline-base chemotherapy
Item
treatment with an anthracycline-based chemotherapy regimen in the adjuvant/neoadjuvant setting with subsequent disease relapse.
boolean
C0392920 (UMLS CUI [1,1])
C0282564 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
breast cancer, unresectable, locally advanced, metastatic
Item
prior chemotherapy for unresectable, locally advanced breast cancer or metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1519810 (UMLS CUI [1,3])
C0677984 (UMLS CUI [1,4])
C0027627 (UMLS CUI [1,5])
concurrent tumor therapy
Item
concurrent administration of any other tumor therapy, including cytotoxic chemotherapy, hormonal therapy, and immunotherapy.
boolean
C0009429 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
brain metastasis, second primary malignancy
Item
known or suspected brain metastasis or second primary malignancy that is clinically detectable at the time of consideration for study enrollment.
boolean
C0220650 (UMLS CUI [1])
C0751623 (UMLS CUI [2])
infection, comorbidities
Item
active infection or other serious condition.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
pregnancy, breast feeding
Item
pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial